In addition, compared with the methylated SEPT9 (septin 9) gene, a blood-based epigenetic biomarker for colon cancer, our cfDNA 5hmC biomarkers registered a significantly further improved overall sensitivity (0.86 vs 0.48 based on public data)32. Here, SEPTIN9 is linked to colonic neoplasm.